PainChek Limited (ASX:PCK)

Australia flag Australia · Delayed Price · Currency is AUD
0.175
+0.010 (6.06%)
At close: Mar 6, 2026
-41.67%
Market Cap 36.58M
Revenue (ttm) 3.44M
Net Income (ttm) -9.22M
Shares Out 209.01M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 56,614
Average Volume 144,980
Open 0.170
Previous Close 0.165
Day's Range 0.170 - 0.175
52-Week Range 0.165 - 1.050
Beta 0.48
RSI 36.96
Earnings Date Apr 30, 2026

About PainChek

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant s... [Read more]

Sector Healthcare
CEO Philip Daffas
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PCK
Full Company Profile

Financial Performance

In fiscal year 2025, PainChek's revenue was 3.36 million, an increase of 25.84% compared to the previous year's 2.67 million. Losses were -7.67 million, -7.65% less than in 2024.

Financial Statements

News

Painchek Ltd (ASX:PCK) (H1 2026) Earnings Call Highlights: Strategic US Expansion and Strong ...

Painchek Ltd (ASX:PCK) (H1 2026) Earnings Call Highlights: Strategic US Expansion and Strong Pipeline Drive Future Growth

4 weeks ago - GuruFocus

Half Year 2026 PainChek Ltd Earnings Call Transcript

Half Year 2026 PainChek Ltd Earnings Call Transcript

4 weeks ago - GuruFocus